Mental health

Study shows a workplace wellness program didn't do much

The first major study on the effectiveness of a workplace wellness program found that it had little impact on health outcomes, spending or utilization, according to a new Harvard study published in JAMA.

Details: It also didn't improve worker attendance or job performance over the 18 months of the study. It did, however, encourage employees to exercise more and improve their weight management.

Looking at ketamine, the short-term wonder antidepressant

Illustration of bottle of antidepressant drug Ketamine with a sad face turning into a happy face
Illustration: Lazaro Gamio/Axios

A key to preventing depression relapse could be figuring out how to maintain the dendritic spines in the neurons, according to a study published on Thursday in Science that examined an antidepressant that's getting a lot of buzz called ketamine.

Why it matters: Depression affects nearly 20% of Americans — 80% of whom will endure a relapse after remission and 30% of whom will have treatment-resistant depression (TRD). Ketamine has been lauded for alleviating TRD in an amazingly short amount of time — but the side effects are quite serious, no one knows quite how it works, and the positive effect doesn't last long.